abstract |
The present invention relates to the use of a quinazolinone compound of formula (I) as a capsaicin receptor antagonist, wherein R 1 , R 2 , R 3 , R 4 , R 5 and m are as defined in the specification and claims. These compounds may be in free form or in salt form, where possible in the form of acid addition salts. |